SUPER
WAITLIST
  1. Home
  2. Stocks
  3. GLAXO
  4. Announcements

GLAXO · PHARMACEUTICALS

GLAXO announcements GlaxoSmithKline Pakistan Limited

GlaxoSmithKline Pakistan Limited (GLAXO) has 100 notices stored from the exchange, from 03 May 2023 to 30 Oct 2026. The newest is dated 30 Oct 2026; the titles below are the exchange’s own words.

Every notice stored, newest first

DateKindTitle as filedPDF
30 Oct 2026Report sent to shareholdersTransmission of Quarterly Report for the Period Ended September 30, 2026PDF
29 Oct 2026Financial resultsFinancial Results for the Quarter Ended September 30, 2026PDF
21 Oct 2026Board meetingBoard Meeting Quarter 3-2026PDF
15 Sep 2026Shariah disclosureShariah Disclosure for the Half Year ended June 30, 2026PDF
11 Sep 2026Dividend or bonus paymentCredit of Interim Cash DividendPDF
03 Sep 2026Management changeAppointment of Chief Financial OfficerPDF
28 Aug 2026Management changeAppointment of Executive DirectorPDF
28 Aug 2026Book closureNotice of interim cash dividend and share book closurePDF
28 Aug 2026Report sent to shareholdersTransmission of Quarterly Report for the Period ended June 30, 2026PDF
27 Aug 2026Book closurePrior Publication of Notice of Interim Cash Dividend and Share Book ClosurePDF
25 Aug 2026Book closureChange in Book Closure DatePDF
25 Aug 2026Financial resultsFinancial Results for the Quarter Ended June 30, 2026PDF
18 Aug 2026Board meetingBoard MeetingPDF
03 Aug 2026Management changeAppointment of Interim/ Acting Chief Financial OfficerPDF
03 Aug 2026Management changeAppointment of Non-Executive DirectorPDF
08 Jun 2026Management changeResignation of Chief Financial Officer & Executive DirectorPDF
01 Jun 2026Management changeResignation of Non-Executive DirectorPDF
25 May 2026Management change(Re) Appointment of Chairperson and Chief Executive OfficerPDF
08 May 2026Corporate briefingVideo Recording of the Corporate Briefing SessionPDF
06 May 2026Dividend or bonus paymentCredit of Final Cash DividendPDF
05 May 2026Corporate briefingPresentation of the Corporate Briefing SessionPDF
30 Apr 2026Corporate briefingCorporate Briefing SessionPDF
30 Apr 2026General meetingCertified True Copy of The Resolutions passed by the shareholders in the Annual General Meeting held on April 30, 2026PDF
29 Apr 2026Report sent to shareholdersTransmission of Quarterly Financial Statements for the Period ended March 31, 2026PDF
27 Apr 2026Financial resultsFinancial Results for the Quarter Ended March 31, 2026PDF
23 Apr 2026General meetingNotice of Election of DirectorsPDF
22 Apr 2026General meetingPrior Publication of Notice of Election of DirectorsPDF
22 Apr 2026Material informationMiscellaneous InformationPDF
21 Apr 2026Material informationMiscellaneous InformationPDF
20 Apr 2026Board meetingBoard Meeting Quarter 1- 2026PDF
09 Apr 2026Report sent to shareholdersTransmission of Annual Financial Statements for the year ended 31-12-2025PDF
09 Apr 2026General meetingNotice of the Annual General MeetingPDF
08 Apr 2026General meetingPrior Publication of Annual General Meeting NoticePDF
07 Apr 2026Management changeAppointment of Non-Executive Director & ChairpersonPDF
06 Apr 2026Book closureChange in book closure date for the 79th AGMPDF
31 Mar 2026Material informationMaterial InformationPDF
26 Mar 2026Financial resultsFinancial Results for the year Ended 2025-12-31PDF
18 Mar 2026Board meetingBoard Meeting Quarter 4, 2025PDF
05 Dec 2025Corporate briefingPresentation for Corporate Briefing Session -2025PDF
03 Dec 2025Corporate briefingNotice of Corporate Briefing Session - 2025PDF
29 Oct 2025Report sent to shareholdersTransmission of Quarterly Report for the period ended September 30, 2025PDF
24 Oct 2025Financial resultsFinancial Results for the Quarter ended September 30, 2025PDF
16 Oct 2025Board meetingNotice of Board of Directors Meeting (Q3-2025)PDF
19 Sep 2025Dividend or bonus paymentCredit of Interim cash dividendPDF
02 Sep 2025Book closureNotice of interim cash dividend and share book closurePDF
01 Sep 2025Book closurePrior Publication of Notice of Interim Cash Dividend and Share Book ClosurePDF
29 Aug 2025Report sent to shareholdersTransmission of Half Yearly Report for the Period ended June 30, 2025PDF
26 Aug 2025Financial resultsFinancial Results for the Quarter ended June 30, 2025PDF
19 Aug 2025Board meetingNotice of Board of Directors Meeting (Q2- 2025)PDF
07 May 2025Dividend or bonus paymentCredit of Final Cash DividendPDF
29 Apr 2025Report sent to shareholdersTransmission of Quarterly Report for the period ended March 31, 2025PDF
28 Apr 2025General meetingCertified True Copy of the Resolutions passed by shareholders in the Annual General Meeting held on April 28, 2025PDF
25 Apr 2025Financial resultsFinancial Results for the Quarter Ended March 31, 2025PDF
17 Apr 2025Board meetingBoard Meeting Quarter ended March 31, 2025PDF
07 Apr 2025Report sent to shareholdersTransmission of Annual Report for the year ended December 31, 2024PDF
07 Apr 2025General meetingNotice of Annual General MeetingPDF
04 Apr 2025General meetingPrior Publication of Annual General Meeting NoticePDF
24 Mar 2025Financial resultsFinancial Results for the Year Ended 31st December 2024PDF
14 Mar 2025Board meetingBoard of Directors Meeting for the year ended December 31, 2024PDF
07 Feb 2025Management changeAppointment of Non-Executive DirectorPDF
18 Nov 2024Material informationMaterial InformationPDF
11 Nov 2024Corporate briefingPresentation of Corporate Briefing Session 2024PDF
08 Nov 2024Corporate briefingNotice of Corporate Briefing Session - 2024PDF
29 Oct 2024Report sent to shareholdersGLAXO | GlaxoSmithKline Pakistan Limited TRANSMISSION OF QUARTERLY ACCOUNTS FOR THE PERIOD ENDED SEP. 30, 2024PDF
28 Oct 2024Financial resultsFinancial Results for the nine months ended September 30,2024PDF
28 Oct 2024Financial resultsFinancial results for the nine months ended September 20, 2024 REVOKEDPDF
21 Oct 2024Board meetingGLAXO | GlaxoSmithKline Pakistan Limited Board MeetingPDF
04 Oct 2024Unusual price movement noticeGLAXO | GlaxoSmithKline Pakistan Limited UNUSUAL MOVEMENT IN THE PRICE OF SHARES OF GlaxoSmithKline Pakistan LimitedPDF
29 Aug 2024Report sent to shareholdersGLAXO | GlaxoSmithKline Pakistan Limited Transmission of Half yearly Report for the Period Ended June 30, 2024PDF
23 Aug 2024Financial resultsGLAXO | GlaxoSmithKline Pakistan Limited Financial Results for the Half Year Ended June 30 2024PDF
16 Aug 2024Board meetingGLAXO | GlaxoSmithKline Pakistan Limited Board MeetingPDF
30 Jul 2024Board meetingGLAXO | GlaxoSmithKline Pakistan Limited GSK Board Meeting Result other than Financial Results July 30 2024PDF
23 Jul 2024Financial resultsGLAXO | GlaxoSmithKline Pakistan Limited Other Than Financial ResultsPDF
11 Jun 2024Management changeAppointment of Company SecretaryPDF
10 Jun 2024Management changeResignation of Company SecretaryPDF
20 May 2024Unusual price movement noticeUnusual Movement in the price of sharesPDF
30 Apr 2024Report sent to shareholdersTransmission of Quarterly Account for the Period Ended March 31, 2024PDF
26 Apr 2024Financial resultsFinancial Results for the quarter ended March 31,2024PDF
24 Apr 2024General meetingCertified True Copy of Resolution passed by the Shareholders in the Annual General Meeting held on April 24, 2024PDF
23 Apr 2024Material informationGLAXO | GlaxoSmithKline Pakistan Limited Material InformationPDF
19 Apr 2024Board meetingBoard Meeting for the quarter ended March 31, 2024PDF
03 Apr 2024General meetingGLAXO | GlaxoSmithKline Pakistan Limited - Notice of Annual General MeetingPDF
03 Apr 2024Report sent to shareholdersTransmission of Annual Report for the year ended December 31, 2023PDF
26 Mar 2024Financial resultsGLAXO | GlaxoSmithKline Pakistan Limited FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 - GLAXOPDF
19 Mar 2024Board meetingBoard of Directors Meeting - 4th Quarter 2023 on 26 March 2024PDF
13 Dec 2023Corporate briefingPresentation of Corporate Briefing Session - 2023PDF
11 Dec 2023Corporate briefingGLAXO | GlaxoSmithKline Pakistan Limited- CORPORATE BRIEFING SESSION - 2023PDF
30 Oct 2023Report sent to shareholdersTranmission of Quarterly Report for the Period Ended September 30, 2023PDF
24 Oct 2023Financial resultsFinancial Results for the Quarter Ended 30-09-2023PDF
17 Oct 2023Board meetingBoard Of Directors MeetingPDF
28 Aug 2023Report sent to shareholdersTransmission of Quarterly Report for the Period Ended June 30, 2023PDF
22 Aug 2023Financial resultsGLAXO | GlaxoSmithKline Pakistan Limited Financial Results for the Half Year Ended June 30, 2023PDF
15 Aug 2023Board meetingBoard MeetingPDF
02 Jun 2023AnnouncementMaterial informaitonPDF
02 Jun 2023Management changeChange of Company SecretaryPDF
30 May 2023Management changeMaterial Information - Resignation of Company SecretaryPDF
24 May 2023General meetingCertified True Copy of Resolution passed by the Shareholders in the Annual General Meeting held on May 24, 2023PDF
17 May 2023General meetingNotice of Election of DirectorsPDF
03 May 2023Report sent to shareholdersTransmission of Annual Report for the Year Ended December 31, 2022PDF
03 May 2023General meetingNotice of Annual General MeetingPDF

Titles are the exchange’s own words. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.

By kind

  • Financial results: 16
  • Board meeting: 15
  • Report sent to shareholders: 15
  • General meeting: 13
  • Management change: 13
  • Corporate briefing: 9
  • Book closure: 6
  • Material information: 5
  • Dividend or bonus payment: 4
  • Unusual price movement notice: 2
  • Announcement: 1
  • Shariah disclosure: 1

Counted from the 100 notices above. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.

More on GLAXO

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .